treatment of melasma
Phase 2
- Conditions
- melasma.Chloasma
- Registration Number
- IRCT2014110919885N1
- Lead Sponsor
- Vice Chancellor for Researc?h, Hamadan university of medical science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
melasma patients with a clinical diagnosis.
Exclusion criteria: Patients who are pregnant or breastfeeding; Patients who are treated with anticonvulsant and corticosteroid drugs; Patients who are treated with OCP; Out Worker's patients; Patients who have a history of sensitivity to AZ or HQ; Patients with underlying systemic disease (hypothyroidism and liver function Diss) are; Patients who have used a local drug during the previous month.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MASI score. Timepoint: 0, 1, 2 and 4 months. Method of measurement: checklist.
- Secondary Outcome Measures
Name Time Method -. Timepoint: -. Method of measurement: -.